WES vs. ABBV
Compare and contrast key facts about Western Midstream Partners, LP (WES) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WES or ABBV.
Correlation
The correlation between WES and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
WES vs. ABBV - Performance Comparison
Loading data...
Key characteristics
WES:
0.41
ABBV:
0.58
WES:
0.88
ABBV:
0.91
WES:
1.11
ABBV:
1.14
WES:
0.86
ABBV:
0.80
WES:
2.24
ABBV:
1.88
WES:
6.40%
ABBV:
8.81%
WES:
27.24%
ABBV:
28.30%
WES:
-93.66%
ABBV:
-45.09%
WES:
-4.43%
ABBV:
-13.89%
Fundamentals
WES:
$14.97B
ABBV:
$328.04B
WES:
$3.34
ABBV:
$2.34
WES:
11.75
ABBV:
79.36
WES:
5.48
ABBV:
0.40
WES:
4.12
ABBV:
5.72
WES:
4.69
ABBV:
231.01
WES:
$3.63B
ABBV:
$57.37B
WES:
$2.52B
ABBV:
$44.44B
WES:
$2.11B
ABBV:
$16.33B
Returns By Period
In the year-to-date period, WES achieves a 6.66% return, which is significantly higher than ABBV's 5.98% return. Over the past 10 years, WES has underperformed ABBV with an annualized return of 2.89%, while ABBV has yielded a comparatively higher 15.66% annualized return.
WES
6.66%
5.22%
8.44%
11.15%
25.03%
46.83%
2.89%
ABBV
5.98%
6.86%
13.06%
16.42%
11.10%
19.52%
15.66%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
WES vs. ABBV — Risk-Adjusted Performance Rank
WES
ABBV
WES vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Western Midstream Partners, LP (WES) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
WES vs. ABBV - Dividend Comparison
WES's dividend yield for the trailing twelve months is around 9.03%, more than ABBV's 3.45% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
WES Western Midstream Partners, LP | 9.03% | 8.33% | 8.52% | 6.80% | 5.69% | 11.25% | 12.45% | 8.28% | 5.44% | 4.04% | 3.86% | 1.73% |
ABBV AbbVie Inc. | 3.45% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
WES vs. ABBV - Drawdown Comparison
The maximum WES drawdown since its inception was -93.66%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for WES and ABBV. For additional features, visit the drawdowns tool.
Loading data...
Volatility
WES vs. ABBV - Volatility Comparison
The current volatility for Western Midstream Partners, LP (WES) is 7.52%, while AbbVie Inc. (ABBV) has a volatility of 10.96%. This indicates that WES experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
WES vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Western Midstream Partners, LP and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
WES vs. ABBV - Profitability Comparison
WES - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Western Midstream Partners, LP reported a gross profit of 705.16M and revenue of 917.12M. Therefore, the gross margin over that period was 76.9%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
WES - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Western Midstream Partners, LP reported an operating income of 409.80M and revenue of 917.12M, resulting in an operating margin of 44.7%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
WES - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Western Midstream Partners, LP reported a net income of 309.01M and revenue of 917.12M, resulting in a net margin of 33.7%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.